Baxter International Inc. Stock
Equities
BAX
US0718131099
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
40.23 USD | -1.71% | +1.46% | +4.06% |
Apr. 23 | Edwards Lifesciences Corporation: The story continues | |
Apr. 15 | Exact Sciences Names Aaron Bloomer CFO | MT |
Financials (USD)
Sales 2024 * | 15.11B | Sales 2025 * | 15.68B | Capitalization | 20.49B |
---|---|---|---|---|---|
Net income 2024 * | 747M | Net income 2025 * | 960M | EV / Sales 2024 * | 1.96 x |
Net Debt 2024 * | 9.15B | Net Debt 2025 * | 8.02B | EV / Sales 2025 * | 1.82 x |
P/E ratio 2024 * |
21.4
x | P/E ratio 2025 * |
17.8
x | Employees | 60,000 |
Yield 2024 * |
2.88% | Yield 2025 * |
3.11% | Free-Float | 74.06% |
Latest transcript on Baxter International Inc.
1 day | -1.71% | ||
1 week | +1.46% | ||
Current month | -5.87% | ||
1 month | -3.73% | ||
3 months | +3.18% | ||
6 months | +25.09% | ||
Current year | +4.06% |
Managers | Title | Age | Since |
---|---|---|---|
Joe Almeida
CEO | Chief Executive Officer | 61 | 15-09-30 |
Joel Grade
DFI | Director of Finance/CFO | 54 | 23-10-17 |
Reaz Rasul
CTO | Chief Tech/Sci/R&D Officer | - | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Oesterle
BRD | Director/Board Member | 73 | 17-02-05 |
Peter Wilver
BRD | Director/Board Member | 64 | 22-05-09 |
Director/Board Member | 64 | 19-02-17 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
13.07% | 215 M€ | +12.27% | - | |
1.23% | 18 M€ | +3.79% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 40.23 | -1.71% | 3,568,051 |
24-04-24 | 40.93 | -0.22% | 2,161,941 |
24-04-23 | 41.02 | +1.53% | 2,646,343 |
24-04-22 | 40.4 | +2.36% | 3,272,883 |
24-04-19 | 39.47 | -0.45% | 2,808,386 |
Delayed Quote Nyse, April 25, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.06% | 20.49B | |
-2.92% | 185B | |
-3.80% | 105B | |
-5.48% | 66.59B | |
+11.22% | 54.66B | |
+16.74% | 47.78B | |
+4.06% | 41.26B | |
+4.56% | 26.95B | |
+1.64% | 26.37B | |
+12.96% | 24.8B |
- Stock Market
- Equities
- BAX Stock